TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets

Libing Song, Liping Liu, Zhiqiang Wu, Yun Li, Zhe Ying, Chuyong Lin, Jueheng Wu, Bo Hu, Shi Yuan Cheng, Mengfeng Li, Jun Li

Research output: Contribution to journalArticlepeer-review

159 Scopus citations


The strength and duration of NF-κB signaling are tightly controlled by multiple negative feedback mechanisms. However, in cancer cells, these feedback loops are overridden through unclear mechanisms to sustain oncogenic activation of NF-κB signaling. Previously, we demonstrated that overexpression of miR-30e*irectly represses IκBα expression and leads to hyperactivation of NF-κB. Here, we report that miR-182 was overexpressed in a different set of gliomas with relatively lower miR-30e*expression and that miR-182 directly suppressed cylindromatosis (CYLD), an NF-κB negative regulator. This suppression of CYLD promoted ubiquitin conjugation of NF-κB signaling pathway components and induction of an aggressive phenotype of glioma cells both in vitro and in vivo. Furthermore, we found that TGF-β induced miR-182 expression, leading to prolonged NF-κB activation. Importantly, the results of these experiments were consistent with an identified significant correlation between miR-182 levels with TGF-β hyperactivation and activated NF-κB in a cohort of human glioma specimens. These findings uncover a plausible mechanism for sustained NF-κB activation in malignant gliomas and may suggest a new target for clinical intervention in human cancer.

Original languageEnglish
Pages (from-to)3563-3578
Number of pages16
JournalJournal of Clinical Investigation
Issue number10
StatePublished - 1 Oct 2012
Externally publishedYes


Dive into the research topics of 'TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets'. Together they form a unique fingerprint.

Cite this